Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $24,432 | 1,591 | 96.1% |
| Education | $978.30 | 47 | 3.8% |
| Gift | $23.38 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,999 | 247 | $0 (2024) |
| Janssen Biotech, Inc. | $2,463 | 205 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $2,355 | 115 | $0 (2024) |
| Lilly USA, LLC | $1,764 | 117 | $0 (2024) |
| UCB, Inc. | $1,286 | 69 | $0 (2024) |
| Amgen Inc. | $1,271 | 73 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,007 | 72 | $0 (2024) |
| LEO Pharma Inc. | $975.31 | 49 | $0 (2024) |
| PFIZER INC. | $873.57 | 55 | $0 (2024) |
| MAYNE PHARMA INC. | $830.81 | 67 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,474 | 196 | ABBVIE INC. ($646.40) |
| 2023 | $4,592 | 244 | AbbVie Inc. ($809.35) |
| 2022 | $4,046 | 223 | ABBVIE INC. ($889.43) |
| 2021 | $3,053 | 192 | AbbVie Inc. ($488.65) |
| 2020 | $2,482 | 154 | AbbVie Inc. ($377.67) |
| 2019 | $2,423 | 173 | Janssen Biotech, Inc. ($334.15) |
| 2018 | $2,774 | 247 | Janssen Biotech, Inc. ($404.15) |
| 2017 | $2,590 | 210 | Janssen Biotech, Inc. ($433.76) |
All Payment Transactions
1,639 individual payment records from CMS Open Payments — Page 1 of 66
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $4.60 | General |
| Category: DERMATOLOGY | ||||||
| 12/20/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: IMMUNOLOGY | ||||||
| 12/19/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Inflammation | ||||||
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.51 | General |
| Category: Immunology | ||||||
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $2.23 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $9.50 | General |
| Category: Immunology | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $16.39 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: ANTIBIOTIC | ||||||
| 12/09/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $25.66 | General |
| 12/05/2024 | Janssen Pharmaceuticals, Inc | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Immunology | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $18.03 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $5.15 | General |
| Category: DERMATOLOGY | ||||||
| 11/26/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $10.37 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $13.91 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Immunology | ||||||
| 11/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.85 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $31.17 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: ANTIBIOTIC | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.95 | General |
| Category: Immunology | ||||||
| 11/11/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $18.95 | General |
| 11/07/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 36 | 9,267 | 18,235 | $1.7M | $747,095 |
| 2022 | 36 | 9,223 | 18,525 | $1.7M | $755,072 |
| 2021 | 33 | 9,463 | 18,802 | $1.9M | $836,611 |
| 2020 | 28 | 8,058 | 15,670 | $1.5M | $656,164 |
All Medicare Procedures & Services
133 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 2,509 | 3,704 | $425,020 | $213,475 | 50.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 921 | 1,237 | $197,920 | $102,786 | 51.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 1,587 | 2,350 | $305,500 | $86,475 | 28.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 740 | 910 | $122,850 | $68,057 | 55.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 676 | 788 | $130,020 | $49,736 | 38.3% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 123 | 140 | $68,600 | $41,981 | 61.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 1,156 | 6,729 | $134,580 | $29,695 | 22.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 149 | 201 | $54,270 | $23,099 | 42.6% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 48 | 65 | $30,875 | $19,892 | 64.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 272 | 272 | $59,840 | $18,571 | 31.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 102 | 102 | $28,560 | $11,332 | 39.7% |
| 96573 | Application of light by qualified health care professional to destroy precancer skin growth | Office | 2023 | 47 | 64 | $19,700 | $8,962 | 45.5% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 93 | 101 | $17,170 | $8,871 | 51.7% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 87 | 97 | $29,585 | $8,165 | 27.6% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 21 | 22 | $15,400 | $7,936 | 51.5% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 46 | 56 | $12,040 | $6,634 | 55.1% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 14 | 14 | $7,630 | $4,595 | 60.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 104 | 133 | $9,310 | $4,453 | 47.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 115 | 123 | $10,455 | $4,382 | 41.9% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 37 | 39 | $13,455 | $4,301 | 32.0% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 45 | 48 | $6,720 | $4,090 | 60.9% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Office | 2023 | 45 | 48 | $6,000 | $2,832 | 47.2% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 14 | 23 | $4,025 | $2,278 | 56.6% |
| 13102 | Complicated repair of wound of trunk, each additional 5.0 cm or less | Office | 2023 | 24 | 24 | $3,360 | $2,161 | 64.3% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 13 | 19 | $3,040 | $1,722 | 56.7% |
About Dr. John Rupp, M.D
Dr. John Rupp, M.D is a Specialist healthcare provider based in Kansas City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1598769473.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Rupp, M.D has received a total of $25,434 in payments from pharmaceutical and medical device companies, with $3,474 received in 2024. These payments were reported across 1,639 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($24,432).
As a Medicare-enrolled provider, Rupp has provided services to 36,011 Medicare beneficiaries, totaling 71,232 services with total Medicare billing of $3.0M. Data is available for 4 years (2020–2023), covering 133 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Other Specialties Dermatology
- Location Kansas City, MO
- Active Since 06/09/2005
- Last Updated 10/14/2020
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1598769473
Products in Payments
- TALTZ (Drug) $1,488
- SKYRIZI (Biological) $1,461
- RINVOQ (Biological) $1,212
- DUPIXENT (Biological) $1,135
- Cimzia (Drug) $1,085
- TREMFYA (Drug) $966.18
- Otezla (Drug) $891.03
- REMICADE (Biological) $850.16
- EUCRISA (Drug) $825.96
- Humira (Biological) $759.72
- Winlevi (Drug) $699.21
- DORYX (Drug) $646.20
- VTAMA (Drug) $593.34
- Sotyktu (Drug) $566.26
- ILUMYA (Biological) $566.06
- ADBRY (Biological) $540.09
- COSENTYX (Biological) $454.85
- Seysara (Drug) $454.76
- HUMIRA (Biological) $447.81
- Tremfya (Drug) $406.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Kansas City
Dr. Andrew Moyes, M.d, M.D
Specialist — Payments: $674,410
Dr. Hinrich Staecker, Md, Phd, MD, PHD
Specialist — Payments: $538,416
Dr. David Robbins, M.d, M.D
Specialist — Payments: $112,639
Dr. Kristen Pope, M.d, M.D
Specialist — Payments: $88,784
Dr. Joseph Barnthouse, M.d, M.D
Specialist — Payments: $12,075
Dr. John Kriet, Md, MD
Specialist — Payments: $9,514